24.01.2013
- AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...
23.01.2013
- Novartis expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition from cheaper drugs, and said its long-standing chairman and...
22.01.2013
- Johnson & Johnson reported better-than-expected fourth-quarter earnings on Tuesday, due in part to a favorable tax rate, and said it is considering selling a $2 billion-a-year...
22.01.2013
- Emelie is plagued by hallucinations and nightmares. When she wakes up, she's often paralysed, unable to breathe properly or call for help. During the day she can barely stay awake...
19.01.2013
- Fighting the flu may soon get easier. As early as next year, more modern and more effective vaccines will hit the market, thanks to investments by the U.S. government and...
18.01.2013
- Roche Holding said U.S. regulators will allow it to begin selling the company's reserve stock of adult Tamiflu capsules, and that the extra supplies of the flu treatment should...
15.01.2013
- Forest Laboratories posted an unexpectedly large loss in its fiscal third quarter as sales of its antidepressant Lexapro were buffeted by generic competition and sales of its...
14.01.2013
- Almac is pleased to announce the expansion of its drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new...
